Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

Polaris Observatory HCV Collaborators

(2017), Lancet Gastroenterol Hepatol, 2(3), 161-76

DOI: 10.1016/S2468-1253(16)30181-9

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Jacobson IM, Lawitz E, Gane EJ, Willems BE, Ruane PJ, Nahass RG, Borgia SM, Shafran SD, Workowski KA, Pearlman B, Hyland RH, Stamm LM, Svarovskaia E, Dvory-Sobol H, Zhu Y, Subramanian GM, Brainard DM, McHutchison JG, Brâu N, Berg T, Agarwal K, Bhandari BR, Davis M, Feld JJ, Dore GJ, Stedman CAM, Thompson AJ, Asselah T, Roberts SK, Foster GR

(2017), Gastroenterology, 153(1), 113-22

DOI: 10.1053/j.gastro.2017.03.047

Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy

Lim L, Thompson A, Patterson S, George J, Strasser S, Lee A, Sievert W, Nicoll A, Desmond P, Roberts S, Marion K, Bowden S, Locarnini S, Angus P

(2017), Liver Int, 37(6), 827-35

DOI: 10.1111/liv.13331

Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese

Ooi GJ, Burton PR, Doyle L, Wentworth JM, Bhathal PS, Sikaris K, Cowley MA, Roberts SK, Kemp W, O'Brien PE, Brown WA

(2017), Obes Surg, 27(1), 115-25

DOI: 10.1007/s11695-016-2246-5

Review article: dyssynergic defaecation and biofeedback therapy in the pathophysiology and management of functional constipation

Skardoon GR, Khera AJ, Emmanuel AV, Burgell RE

(2017), Aliment Pharmacol Ther, 46(4), 410-23

DOI: 10.1111/apt.14174

New onset vitiligo following commencement of infliximab in CrohnÌs disease

Luber R, Chamberlain AJ, Sparrow M

(2017), Intern Med J, 47(8), 972-3

DOI: 10.1111/imj.13498

Declining mortality in critically ill patients with cirrhosis in Australia and New Zealand between 2000 and 2015

Majumdar A, Bailey M, Kemp WM, Bellomo R, Roberts SK, Pilcher D

(2017), J Hepatol, 67(6), 1185-93

DOI: 10.1016/j.jhep.2017.07.024

The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review

Paris T, George ES, Roberts SK, Tierney AC

(2017), Eur J Gastroenterol Hepatol, 29(8), 867-78

DOI: 10.1097/MEG.0000000000000890

Adding glucose to food and solutions to enhance fructose absorption is not effective in preventing fructose-induced functional gastrointestinal symptoms: randomised controlled trials in patients with fructose malabsorption

Tuck CJ, Ross LA, Gibson PR, Barrett JS, Muir JG

(2017), J Hum Nutr Diet, 30(1), 73-82

DOI: 10.1111/jhn.12409

Author Reply-Bariatric surgery and liver function tests in nonalcoholic fatty liver disease

Ooi GJ, Burton PR, Kemp WW, Roberts SK, Brown WA

(2017), Obes Surg, 27(4), 1060

Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps

Burgess NG, Pellise M, Nanda KS, Hourigan LF, Zanati SA, Brown GJ, Singh R, Williams SJ, Raftopoulos SC, Ormonde D, Moss A, Byth K, P'Ng H, McLeod D, Bourke MJ

(2016), Gut, 65(3)

Cost analysis of endoscopic mucosal resection vs surgery for large laterally spreading colorectal lesions

Jayanna M, Burgess NG, Singh R, Hourigan LF, Brown GJ, Zanati SA, Moss A, Lim J, Sonson R, Williams SJ, Bourke MJ

(2016), Clin Gastroenterol Hepatol, 14(2)

Prediction of clinically significant bleeding following wide-field endoscopic resection of large sessile and laterally spreading colorectal lesions: a clinical risk score

Bahin FF, Rasouli KN, Byth K, Hourigan LF, Singh R, Brown GJ, Zanati SA, Moss A, Raftopoulos S, Williams SJ, Bourke MJ

(2016), Am J Gastroenterol, 111(8)

Intestinal ultrasound in inflammatory bowel disease

Asthana AK

(2016), J Gastroenterol Hepatol, 31 Suppl 1

WFUMB position paper. Learning gastrointestinal ultrasound: theory and practice

Atkinson NS, Bryant RV, Dong Y, Maaser C, Kucharzik T, Maconi G, Asthana AK, Blaivas M, Goudie A, Gilja OH, NolsØe C, Nürnberg D, Dietrich CF

(2016), Ultrasound Med Biol, 42(12)

Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis

Taylor KM, Sparrow MP

(2016), Aliment Pharmacol Ther, 43(9)

Appropriateness of testing for anti-tumor necrosis factor agent and antibody concentrations, and interpretation of results

Melmed GY, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Bressler B, Cheifetz AS, Devlin SM, Raffals LE, Vande Casteele N, Mould DR, Colombel JF, Dubinsky M, Sandborn WJ, Siegel CA

(2016), Clin Gastroenterol Hepatol, 14(9)

A retrospective comparison of infliximab versus adalimumab as induction and maintenance therapy for Crohn disease

Varma P, Paul E, Huang C, Headon B, Sparrow MP

(2016), Intern Med J, 46(7)

Recommendations for quality colonoscopy reporting for patients with inflammatory bowel disease: results from a RAND appropriateness panel

Devlin SM, Melmed GY, Irving PM, Rubin DT, Kornbluth A, Kozuch PL, Raffals LE, Velayos FS, Sparrow MP, Baidoo L, Bressler B, Cheifetz AS, Jones J, Kaplan GG, Siegel CA

(2016), Inflamm Bowel Dis, 22(6)

Thiopurines best practice

Friedman A

(2016), J Gastroenterol Hepatol, 31 Suppl 1

12 13 14 15 16